0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pharmapoint alzheimer s disease global drug forecast market analysis 2022.Your search for "" gave back 1533059 results.
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hepatocyte Growth Factor - Pipeline Review, H2 2019 Summary Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 Summary According to the recently published report '5-Hydroxytryptamine Receptor 6...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2018 Summary 5-Hydroxytryptamine Receptor 6 (5 HT6 or...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Highlights The global Alzheimer’s Disease Therapeutics and Diagnostics market was valued at US$ 6867.4 million in 2022 and is anticipated to reach US...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Drugs In Development, 2021 Summary Muscarinic Acetylcholine Receptor M2 (CHRM2) pipeline Target...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H2 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Muscarinic Acetylcholine Receptor M4 (CHRM4) - Drugs In Development, 2021 Summary Muscarinic Acetylcholine Receptor M4 (CHRM4) - Muscarinic...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Market Analysis and Insights: Global Alzheimer’s Disease Therapeutics and Diagnostics Market The global Alzheimer’s Disease Therapeutics and...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Down Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Down...
Catalog:
Global Markets Direct
January 2018
Price: USD 2,000.00
Gamma Secretase - Pipeline Review, H2 2020 Summary According to the recently published report 'Gamma Secretase - Pipeline Review, H2 2020...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
The global Early Diagnosis Kit For Alzheimer's Disease market is projected to reach US$ 293 million in 2029, increasing from US$ 215 million in...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 Summary According to the recently published report 'Gamma Secretase - Drugs In...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
The global Early Diagnosis Kit For Alzheimer's Disease market was valued at US$ 215 million in 2023 and is anticipated to reach US$ 293 million...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Muscarinic Acetylcholine Receptor M4 - Pipeline Review, H2 2019 Summary Muscarinic Acetylcholine Receptor M4 (CHRM4) pipeline Target constitutes...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
